⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing
prnewswire.com
NVS
PFE
SNY
AZN
PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing
prnewswire.com
NVS
PFE
SNY
AZN
Cell and Gene Therapy Global Market Opportunities And Strategies To 2035 Published — Analyzes Hospitals, Cancer Care Centers and Other End Users
globenewswire.com
GILD
NVS
BMY
JNJ
SRPT
VRTX
AMGN
ENT Disorder Treatment Market to Reach US$58 Billion by 2034, Driven by Digital Diagnostics and Minimally Invasive Car
globenewswire.com
GSK
SNY
PFE
AZN
NVS
ABBV
JNJ
MRK
MDT
SN
BSX
TEVA
SUN
Duchenne Muscular Dystrophy Treatment Market Report (2025-2034) Published, Segments Intravenous, Subcutaneous, and Oral Routes Across Three Pharmacy Channels
globenewswire.com
SRPT
PFE
BIIB
REGN
GILD
JNJ
ABBV
NVS
SNY
CAPR
SLDB
WVE
EDIT
VivioMD GLP-1 Program Overview 2026: Semaglutide, Tirzepatide, Pricing, Safety and Refund Terms Investigated
accessnewswire.com
NVS
LLY
Juvenile Idiopathic Arthritis Market is Forecast to Grow at a 4.6% CAGR from 2026 to 2036 As Biologics, JAK Inhibitors, and Emerging Targeted Therapies Reshape Pediatric Arthritis Treatment.
globenewswire.com
ABBV
SNY
REGN
JNJ
NVS
BMY
LLY
PFE
UCB
Global Carcinoid Syndrome Market Poised for Growth Through 2035 as Treatment Innovation and Diagnosis Rates Advance
globenewswire.com
NVS
LXRX
CRNX
Alport Syndrome Market to Grow at a Tremendous 47% CAGR Through 2036, Driven by Emerging Therapies and Expanding Clinical Pipeline | DelveInsight
prnewswire.com
ELOX
EVTC
NVS
TARA
Biotech Visionary John F. Crowley to Keynote Emily Whitehead Foundation's 2026 Believe Ball in Philadelphia
prnewswire.com
NVS